# p63 in skin homeostasis and disease: molecular mechanisms and therapeutic potentials

**Authors:** Yujia Cong, Zhenglin He, Hanming Hao, Haoran Chen, Anqi Chen, Chunyi Li, Yue Hu, Xianling Cong

PMC · DOI: 10.1038/s41420-026-03060-8 · Cell Death Discovery · 2026-03-24

## TL;DR

This paper reviews how the p63 gene helps maintain healthy skin and contributes to skin diseases, focusing on its different forms and roles in development and disease.

## Contribution

The paper provides a comprehensive review of p63's molecular mechanisms and dual roles in skin health and disease, emphasizing its therapeutic potential.

## Key findings

- p63 regulates skin development through epithelial fate determination and barrier formation.
- Mutations in p63 are linked to ectodermal dysplasia and other skin disorders.
- p63 isoforms TAp63 and ΔNp63 have distinct roles in cell proliferation and stress responses.

## Abstract

As a pivotal member of the p53 family, the p63 gene plays an indispensable role in skin homeostasis and development. The gene encodes multiple isoforms, primarily TAp63 and ΔNp63, which differentially regulate cell proliferation, differentiation, and stress responses through complementary mechanisms. This comprehensive review systematically examines the molecular mechanisms and cellular functions of p63 in cutaneous biology, with particular emphasis on its dual roles in maintaining skin integrity and contributing to disease pathogenesis. We detail the essential functions of p63 in skin development, encompassing epithelial fate determination, chromatin remodeling, cell adhesion, and barrier formation, while also exploring its involvement in skin regeneration and differentiation via metabolic reprogramming and stem cell modulation. Furthermore, we analyze how mutations in p63 underlie ectodermal dysplasia and various dermatological disorders, underscoring the gene’s fundamental importance in cutaneous health. By integrating current knowledge of the diverse biological roles of p63 and its associated therapeutic potential as a target, this review highlights its central significance in both skin physiology and pathology.

## Linked entities

- **Genes:** RPE65 (retinoid isomerohydrolase RPE65) [NCBI Gene 6121], TP53 (tumor protein p53) [NCBI Gene 7157], LOC143057788 (cellular tumor antigen p53-like) [NCBI Gene 143057788]
- **Diseases:** ectodermal dysplasia (MONDO:0009773)

## Full-text entities

- **Genes:** PTEN (phosphatase and tensin homolog) [NCBI Gene 5728] {aka 10q23del, BZS, CWS1, DEC, GLM2, MHAM}, IRF6 (interferon regulatory factor 6) [NCBI Gene 3664] {aka LPS, OFC6, PIT, PPS, PPS1, VWS}, RIPK4 (receptor interacting serine/threonine kinase 4) [NCBI Gene 54101] {aka ANKK2, ANKRD3, CHANDS, DIK, NKRD3, PKK}, YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413] {aka COB1, YAP, YAP-1, YAP2, YAP65, YKI}, HDAC2 (histone deacetylase 2) [NCBI Gene 3066] {aka HD2, KDAC2, RPD3, YAF1}, PERP (p53 apoptosis effector related to PMP22) [NCBI Gene 64065] {aka EKVP7, KCP1, KRTCAP1, OLMS2, PIGPC1, THW}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, CREBBP (CREB binding lysine acetyltransferase) [NCBI Gene 1387] {aka CBP, KAT3A, MKHK1, RSTS, RSTS1}, HELLS (helicase, lymphoid specific) [NCBI Gene 3070] {aka ICF4, LSH, Nbla10143, PASG, SALNR, SMARCA6}, SFN (stratifin) [NCBI Gene 2810] {aka YWHAS}, GPX2 (glutathione peroxidase 2) [NCBI Gene 2877] {aka GI-GPx, GPRP, GPRP-2, GPx-2, GPx-GI, GSHPX-GI}, MIR203A (microRNA 203a) [NCBI Gene 406986] {aka MIR203, MIRN203, hsa-mir-203a, miR-203, miRNA203, mir-203a}, CCND1 (cyclin D1) [NCBI Gene 595] {aka BCL1, D11S287E, PRAD1, U21B31}, Dst (dystonin) [NCBI Gene 13518] {aka 2310001O04Rik, A830042E19Rik, BP230, BPAG1-n, Bpag, Bpag1}, PFKFB3 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3) [NCBI Gene 5209] {aka IPFK2, PFK2, iPFK-2}, Klf4 (Kruppel-like transcription factor 4 (gut)) [NCBI Gene 16600] {aka EZF, Gklf, Zie}, SMARCA4 (SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4) [NCBI Gene 6597] {aka BAF190, BAF190A, BRG1, CSS4, MRD16, OTSC12}, CHD1 (chromodomain helicase DNA binding protein 1) [NCBI Gene 1105] {aka CHD-1, PILBOS}, FGFR3 (fibroblast growth factor receptor 3) [NCBI Gene 2261] {aka ACH, CD333, CEK2, HSFGFR3EX, JTK4}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, GRHL2 (grainyhead like transcription factor 2) [NCBI Gene 79977] {aka BOM, DFNA28, ECTDS, PPCD4, TFCP2L3}, HK2 (hexokinase 2) [NCBI Gene 3099] {aka HKII, HXK2}, LINC00302 (long intergenic non-protein coding RNA 302) [NCBI Gene 388699] {aka C1orf46, NCRNA00302, xp33}, CDK12 (cyclin dependent kinase 12) [NCBI Gene 51755] {aka CRK7, CRKR, CRKRS}, EP300 (EP300 lysine acetyltransferase) [NCBI Gene 2033] {aka KAT3B, MKHK2, RSTS2, p300}, DNMT3A (DNA methyltransferase 3 alpha) [NCBI Gene 1788] {aka DNMT3A2, HESJAS, M.HsaIIIA, TBRS}, AXIN2 (axin 2) [NCBI Gene 8313] {aka AXIL, ODCRCS}, SOD2 (superoxide dismutase 2) [NCBI Gene 6648] {aka GC1, GClnc1, IPO-B, IPOB, MNSOD, MVCD6}, Itga3 (integrin alpha 3) [NCBI Gene 16400] {aka CD49C, GAPB3}, NQO1 (NAD(P)H quinone dehydrogenase 1) [NCBI Gene 1728] {aka DHQU, DIA4, DTD, NMOR1, NMORI, QR1}, FGFR2 (fibroblast growth factor receptor 2) [NCBI Gene 2263] {aka BBDS, BEK, BFR-1, CD332, CEK3, CFD1}, ACTL6A (actin like 6A) [NCBI Gene 86] {aka ACTL6, ARPN-BETA, Arp4, BAF53A, INO80K, SMARCN1}, Bcam (basal cell adhesion molecule) [NCBI Gene 57278] {aka 1200005K12Rik, B-CAM, Gplu, Lu}, TP73 (tumor protein p73) [NCBI Gene 7161] {aka CILD47, P73}, LAMC2 (laminin subunit gamma 2) [NCBI Gene 3918] {aka B2T, BM600, CSF, EBR2, EBR2A, JEB3A}, Trp63 (transformation related protein 63) [NCBI Gene 22061] {aka Ket, P51/P63, P63, P73l, Tp63, Trp53rp1}, KMT2D (lysine methyltransferase 2D) [NCBI Gene 8085] {aka AAD10, ALR, BCAHH, CAGL114, KABUK1, KMS}, JUNB (JunB proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 3726] {aka AP-1}, EVPL (envoplakin) [NCBI Gene 2125] {aka EVPK}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, FOXM1 (forkhead box M1) [NCBI Gene 2305] {aka FKHL16, FOXM1A, FOXM1B, FOXM1C, HFH-11, HFH11}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, MAPK14 (mitogen-activated protein kinase 14) [NCBI Gene 1432] {aka CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2}, BRD4 (bromodomain containing 4) [NCBI Gene 23476] {aka CAP, CDLS6, FSHRG4, HUNK1, HUNKI, MCAP}, IGKV7-3 (immunoglobulin kappa variable 7-3 (pseudogene)) [NCBI Gene 28905] {aka B1, IGKV73}, NR3C1 (nuclear receptor subfamily 3 group C member 1) [NCBI Gene 2908] {aka GCCR, GCR, GCRST, GR, GRL}, MIR21 (microRNA 21) [NCBI Gene 406991] {aka MIRN21, hsa-mir-21, miR-21, miRNA21}, RUNX1 (RUNX family transcription factor 1) [NCBI Gene 861] {aka AML1, AML1-EVI-1, AMLCR1, CBF2alpha, CBFA2, EVI-1}, SATB1 (SATB homeobox 1) [NCBI Gene 6304] {aka DEFDA, DHDBV, KTZSL}, LMNB1 (lamin B1) [NCBI Gene 4001] {aka ADLD, LMN, LMN2, LMNB, MCPH26}, TP63 (tumor protein p63) [NCBI Gene 8626] {aka AIS, B(p51A), B(p51B), EEC3, KET, LMS}, KRT14 (keratin 14) [NCBI Gene 3861] {aka CK14, EBS1, EBS1A, EBS1B, EBS1C, EBS1D}, BMP1 (bone morphogenetic protein 1) [NCBI Gene 649] {aka OI13, PCOLC, PCP, TLD}, REXO2 (RNA exonuclease 2) [NCBI Gene 25996] {aka CGI-114, REX2, RFN, SFN}, H3P16 (H3 histone pseudogene 16) [NCBI Gene 644914] {aka H3.6, H3F3AP6, p21}, SOX3 (SRY-box transcription factor 3) [NCBI Gene 6658] {aka GHDX, MRGH, PHP, PHPX, SOXB}, HDAC1 (histone deacetylase 1) [NCBI Gene 3065] {aka GON-10, HD1, KDAC1, RPD3, RPD3L1}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, Hbp1 (high mobility group box transcription factor 1) [NCBI Gene 73389] {aka 1700058O05Rik, C330012F01Rik}, RHBDF2 (rhomboid 5 homolog 2) [NCBI Gene 79651] {aka RHBDL5, RHBDL6, TOC, TOCG, iRhom2}
- **Diseases:** corneal epithelial degeneration (MESH:C536444), non-syndromic cleft lip/palate (MESH:C566121), EEC (MESH:C565062), RHS (MESH:C535289), hereditary disorders (MESH:D009386), cardiotoxic (MESH:D066126), epidermal (MESH:D004814), genetic diseases (MESH:D030342), erosions (MESH:D014077), Skin diseases (MESH:D012871), LMS limb mammary syndrome (MESH:C537878), LSCD (MESH:D000092423), craniofacial malformations (MESH:D019465), inflammation (MESH:D007249), Cutaneous squamous cell carcinoma (MESH:D002294), dental anomalies (OMIM:614188), edema (MESH:D004487), cutaneous (MESH:D018366), non-melanoma skin malignancy (MESH:D008545), nail dysplasia (MESH:C538333), xerotic fragile skin (MESH:C536156), limb malformations (MESH:C535856), mammary hypoplasia (MESH:D005348), Hutchinson-Gilford progeria syndrome (MESH:D011371), erythema (MESH:D004890), limb defects (MESH:C537754), vision loss (MESH:D014786), AEC syndrome (MESH:C535847), tumor (MESH:D009369), ankyloblepharon (MESH:C565138), AD (MESH:D003876), nipple aplasia (OMIM:616001), syndactyly (MESH:D013576), inflammatory skin disorders (MESH:D012868), nail dystrophy (MESH:D009260), osteopenia (MESH:D001851), ADULT syndrome (MESH:C538052), dermatological disorders (MESH:D000168), alopecia (MESH:D000505), papular eruptions (MESH:C537169), hypodontia (MESH:D000848), ED syndromes (MESH:D004476), cleft lip (MESH:D002971), corneal opacities (MESH:D003318), scleroderma (MESH:D012595), lacrimal duct anomalies (MESH:D007767), microstomia (MESH:D008865), keloid (MESH:D007627), trauma (MESH:D014947), linear macules (MESH:C537836), CL/P (MESH:D002972), skin cancer (MESH:D012878), corneal defects (MESH:D003316), carcinogenesis (MESH:D063646), Progeroid syndromes (MESH:C536423), lipodystrophy (MESH:D008060), cutaneous atrophy (MESH:D001284), ectrodactyly (MESH:C574275), LMS (MESH:C535903), dysfunction (MESH:D006331)
- **Chemicals:** ATP (MESH:D000255), Glucose (MESH:D005947), reactive oxygen species (MESH:D017382), APR-246 (MESH:C533410), phospholipids (MESH:D010743), cholesterol esters (MESH:D002788), lipid (MESH:D008055), doxorubicin (MESH:D004317), triglycerides (MESH:D014280), diMe-doxorubicin (-), anthracyclines (MESH:D018943), monounsaturated fatty acid (MESH:D005229)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Human papillomavirus (species) [taxon 10566]
- **Mutations:** R243W, R279, R298Q, R204Q, L514F, R204, R279H, R304W, R311K, R227Q, R227

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13039162/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13039162/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC13039162/full.md

---
Source: https://tomesphere.com/paper/PMC13039162